Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Beijing Leadman Biochemistry

Central Bureau Observation of Nucleic Acid Testing①|The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

  • Post date May 12, 2022 — 13:32 Post Lock Login to View

Read More

Leadman will distribute 0.2 yuan for every 10 shares in 2021. The record date is May 18

  • Post date May 10, 2022 — 23:31 Post Lock Login to View

Read More

Leadman (300289): 2021 Annual Equity Distribution Implementation Announcement CFi.CN

  • Post date May 10, 2022 — 21:17 Post Lock Login to View

Read More

Leadman's net profit in the first quarter of 2022 was 12.1091 million, a year-on-year increase of 93.14%, revenue from new crown detection reagent products increased – yqqlm

  • Post date April 23, 2022 — 19:57 Post Lock Login to View

Read More

Leadman (300289): Resolution of the Fourth Meeting of the Fifth Board of Directors CFi.CN

  • Post date April 23, 2022 — 19:46 Post Lock Login to View

Read More

[First Quarterly Report] Leadman (300289): 2022 First Quarterly Report Disclosure Announcement CFi.CN Zhongcai Network

  • Post date April 23, 2022 — 19:45 Post Lock Login to View

Read More

Leadman (300289): Resolution of the 3rd meeting of the 5th Supervisory Committee CFi.CN

  • Post date April 23, 2022 — 19:45 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.